{
    "4800": {
        "explanation_text": "Displaced fracture of cuboid bone of left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of foot fractures or significant trauma to the left foot.The patient presented with localized pain, swelling, and inability to bear weight on the left foot after a fall.X-ray of the left foot revealed a displaced fracture of the cuboid bone.Displaced fracture of cuboid bone of left foot, initial encounter for closed fracture. The patient sustained a displaced fracture of the cuboid bone of the left foot after a fall, as confirmed by X-ray.The patient reports the onset of symptoms immediately after the fall. Physical examination shows tenderness, swelling, and bruising over the cuboid bone area. No other injuries were noted.The patient's left foot was immobilized with a cast, and pain management was initiated. The patient was advised to avoid weight-bearing activities and follow up in two weeks for reassessment.The patient was discharged in stable condition with instructions for cast care, pain management, and follow-up. The patient was educated on signs of complications and advised to return earlier if any concerns arise.45FemaleCaucasian"
    },
    "4801": {
        "explanation_text": "Displaced fracture of second metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of foot fractures or significant trauma to the left foot.The patient presented with localized pain, swelling, and tenderness on the dorsum of the left foot.X-ray imaging revealed a displaced fracture of the second metatarsal bone in the left foot.Displaced fracture of second metatarsal bone, left foot, initial encounter for closed fracture. The patient presented with localized pain, swelling, and tenderness on the dorsum of the left foot. X-ray imaging confirmed a displaced fracture of the second metatarsal bone in the left foot.The patient reports that the pain started after accidentally dropping a heavy object on their left foot. Physical examination showed limited range of motion and point tenderness over the second metatarsal bone.The patient was placed in a short leg cast for immobilization and advised to avoid weight-bearing on the left foot. Prescribed pain medication and instructed on RICE (Rest, Ice, Compression, Elevation) protocol.The patient was discharged in stable condition with instructions to follow up with orthopedics in two weeks for cast removal and further evaluation.45FemaleCaucasian"
    },
    "4802": {
        "explanation_text": "Displaced fracture of third metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no previous history of fractures or foot injuries.The patient presented with immediate pain, swelling, and inability to bear weight on the left foot after accidentally dropping a heavy object on it.X-ray of the left foot revealed a displaced fracture of the third metatarsal bone.Displaced fracture of third metatarsal bone, left foot, initial encounter for closed fracture. The patient presents with immediate pain, swelling, and inability to bear weight on the left foot after accidentally dropping a heavy object on it.The patient's left foot is swollen, tender to touch, and there is visible deformity at the base of the third toe. X-ray confirmed a displaced fracture of the third metatarsal bone.The patient was placed in a short leg cast for immobilization and advised to avoid weight-bearing activities. Prescribed pain medication and instructed on RICE (Rest, Ice, Compression, Elevation) protocol.The patient was discharged with instructions to follow up with orthopedics in two weeks for a repeat X-ray to assess healing progress.42FemaleCaucasian"
    },
    "4803": {
        "explanation_text": "Displaced fracture of fourth metatarsal bone, right foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of fractures or bone-related issues.The patient presented with localized pain, swelling, and tenderness on the right foot, specifically over the fourth metatarsal bone.X-ray of the right foot revealed a displaced fracture of the fourth metatarsal bone.Displaced fracture of fourth metatarsal bone, right foot, initial encounter for closed fracture. Verbatim: 'Patient presents with a displaced fracture of the fourth metatarsal bone in the right foot.'Upon examination, there was visible deformity over the fourth metatarsal bone with pain on palpation. No neurovascular deficits noted.The patient's right foot was immobilized with a cast, and pain management was initiated. Instructions for non-weight bearing were given, and a follow-up appointment was scheduled.42FemaleCaucasian"
    },
    "4804": {
        "explanation_text": "Displaced fracture of fifth metatarsal bone, right foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of fractures or foot injuries.The patient presented with acute pain, swelling, and tenderness on the lateral aspect of the right foot.X-ray of the right foot revealed a displaced fracture of the fifth metatarsal bone.Displaced fracture of the fifth metatarsal bone, right foot, initial encounter for closed fracture. Verbatim: 'Displaced fracture of the fifth metatarsal bone, right foot, initial encounter for closed fracture.'The patient reported that the injury occurred while playing soccer when he landed awkwardly on his right foot. Physical examination revealed point tenderness over the proximal diaphysis of the fifth metatarsal bone.The patient's right foot was immobilized with a short leg cast, and he was advised non-weight bearing for six weeks. Prescribed pain management with acetaminophen.The patient was discharged in a stable condition with instructions for cast care and a follow-up appointment in two weeks.32MaleCaucasian"
    },
    "4805": {
        "explanation_text": "Displaced fracture of fifth metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of previous fractures or foot injuries.The patient presented with significant pain, swelling, and difficulty bearing weight on the left foot following a misstep.X-ray of the left foot revealed a displaced fracture of the fifth metatarsal bone.Displaced fracture of fifth metatarsal bone, left foot, initial encounter for closed fracture. The patient sustained an injury resulting in a displaced fracture of the fifth metatarsal bone in the left foot.On examination, there was tenderness, swelling, and slight bruising over the proximal portion of the left foot. The patient's neurovascular status was intact distally.The patient's left foot was immobilized with a below-the-knee cast. Analgesics were prescribed for pain management, and the patient was advised to avoid weight-bearing activities.The patient was discharged in stable condition with instructions to follow up with orthopedics in two weeks for cast removal and further evaluation.42FemaleCaucasian"
    },
    "4806": {
        "explanation_text": "Sprain of tibiofibular ligament of right ankle, initial encounter.",
        "symptom_text": "The patient has no history of ankle sprains or fractures.The patient presented with pain, swelling, and limited range of motion in the right ankle.X-ray of the right ankle showed no signs of fracture.Sprain of tibiofibular ligament of right ankle, initial encounter (ICD-10-CM code S93431A): The patient presents with pain, swelling, and limited range of motion in the right ankle. X-ray ruled out any fractures, confirming the diagnosis of a sprain of the tibiofibular ligament of the right ankle.The patient reports twisting the right ankle during a basketball game yesterday. Tenderness and swelling are noted on the lateral aspect of the ankle. No ecchymosis observed. X-ray findings were negative for fractures.RICE protocol (Rest, Ice, Compression, Elevation) advised. Prescribed NSAIDs for pain management. Ankle brace provided for support. Follow-up scheduled in one week.The patient was educated on home care measures for ankle sprains and the importance of keeping weight off the affected ankle. Improvement in symptoms noted upon discharge.28FemaleCaucasian"
    },
    "4807": {
        "explanation_text": "Sprain of tibiofibular ligament of left ankle, initial encounter.",
        "symptom_text": "The patient has no history of previous ankle injuries or ligament sprains.The patient presented with acute pain, swelling, and limited range of motion in the left ankle after twisting it during a basketball game.X-ray of the left ankle showed no evidence of fracture but revealed soft tissue swelling indicative of a ligament sprain.Sprain of tibiofibular ligament of left ankle, initial encounter (ICD-10-CM code S93432A).On examination, there was tenderness over the tibiofibular ligament with no bony abnormalities. The patient had pain on weight-bearing and mild bruising around the left ankle.The patient was advised R.I.C.E (Rest, Ice, Compression, Elevation) protocol, prescribed NSAIDs for pain, and referred to physical therapy for rehabilitation.The patient was discharged with instructions for home care, gradual return to activities, and a follow-up appointment in two weeks for reevaluation.28FemaleCaucasian"
    },
    "4808": {
        "explanation_text": "Other foreign object in trachea causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory conditions or foreign body aspirations.The patient presented with sudden onset choking, coughing, and difficulty breathing after accidentally inhaling a foreign object.X-ray imaging revealed the presence of a foreign object in the trachea causing airway obstruction.Other foreign object in trachea causing asphyxiation, initial encounter. Verbatim EHR quote justifying the code: 'Patient aspirated a foreign object leading to tracheal obstruction and subsequent asphyxiation.'The patient's airway was immediately secured, and the foreign object was successfully removed via bronchoscopy.The patient was closely monitored in the ICU, received oxygen therapy, and was started on antibiotics to prevent infection.The patient showed significant improvement, with no signs of respiratory distress upon discharge. Follow-up appointment scheduled in one week for a check-up.45MaleCaucasian"
    },
    "4809": {
        "explanation_text": "Food in other parts of respiratory tract causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory conditions or foreign body aspiration.The patient presented with sudden onset coughing, choking, and difficulty breathing after accidentally inhaling a piece of food.Chest X-ray showed no signs of fractures or foreign objects in the lungs.Food in other parts of respiratory tract causing asphyxiation, initial encounter. Verbatim EHR quote justifying the code: 'Patient accidentally inhaled a piece of food, leading to acute asphyxiation.'The patient's airway was cleared, and oxygen saturation levels improved after the removal of the food particle.The patient was monitored closely, received oxygen therapy, and was advised on airway safety measures.The patient was discharged in stable condition with instructions to follow up if any respiratory symptoms reoccur.45FemaleCaucasian"
    },
    "4810": {
        "explanation_text": "Other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory issues or foreign body aspiration.The patient presented with sudden onset choking, coughing, and difficulty breathing after accidentally inhaling a foreign object.Chest X-ray revealed the presence of a foreign object in the lower respiratory tract.Foreign object in other parts of respiratory tract causing asphyxiation, initial encounter. The patient accidentally inhaled a foreign object, leading to asphyxiation.The patient is stable now after the successful removal of the foreign object from the respiratory tract.The patient underwent bronchoscopy for the removal of the foreign object. Oxygen support was provided during the procedure.The patient was discharged in good condition with instructions to follow up if any respiratory symptoms reoccur.45MaleCaucasian"
    },
    "4811": {
        "explanation_text": "Unspecified foreign body in respiratory tract, part unspecified causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory issues or foreign body aspiration.The patient presented with sudden onset choking, coughing, and difficulty breathing after accidentally inhaling a foreign object.Chest X-ray showed air trapping and hyperinflation in the lungs, consistent with airway obstruction.Unspecified foreign body in respiratory tract, part unspecified causing asphyxiation, initial encounter. The patient accidentally inhaled an unspecified foreign body causing immediate asphyxiation, leading to the current presentation.The patient's airway was immediately secured, and emergency bronchoscopy was performed to remove the foreign body. The patient responded well to the intervention with resolution of symptoms.The patient was closely monitored in the ICU post-bronchoscopy. Oxygen therapy was initiated, and antibiotics were administered to prevent any secondary infections. The patient was kept nil per os (NPO) until full recovery.The patient's condition significantly improved post-bronchoscopy, with no signs of respiratory distress. The patient was discharged home with instructions for a follow-up appointment in one week.45MaleCaucasian"
    },
    "4812": {
        "explanation_text": "Food in esophagus causing other injury, initial encounter.",
        "symptom_text": "The patient has a history of gastroesophageal reflux disease (GERD) and occasional dysphagia.The patient presented with acute chest pain, difficulty swallowing, and a sensation of food stuck in the chest.Upper endoscopy revealed a food bolus impacted in the lower esophagus causing mucosal injury.Food in esophagus causing other injury, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with a food bolus impacted in the lower esophagus leading to mucosal injury.'Upon examination, the patient had localized tenderness over the lower sternum area. No signs of respiratory distress were noted.The patient was given IV fluids, and an esophagoscopy was performed to remove the food bolus. Proton pump inhibitors were prescribed for GERD management.The patient's symptoms resolved post-procedure, and they were discharged with instructions for a soft diet and follow-up with a gastroenterologist in two weeks.56FemaleCaucasian"
    },
    "4813": {
        "explanation_text": "Foreign body in stomach, initial encounter.",
        "symptom_text": "No history of swallowing foreign objects or gastrointestinal issues.Patient presented with abdominal pain, nausea, and vomiting after accidentally ingesting a foreign object.Abdominal X-ray showing a radiopaque foreign body in the stomach.Foreign body in stomach, initial encounter. Verbatim EHR quote justifying the code: 'Patient accidentally ingested a foreign body, now presenting with abdominal pain, nausea, and vomiting. Abdominal X-ray confirms the presence of a radiopaque foreign body in the stomach.'Patient stable, no signs of respiratory distress. Advised endoscopy for removal of the foreign body.NPO status, IV fluids, and preparation for endoscopic removal of the foreign body.Patient successfully underwent endoscopic removal of the foreign body without complications. Discharged with instructions for follow-up care.35FemaleCaucasian"
    },
    "4814": {
        "explanation_text": "Foreign body in small intestine, initial encounter.",
        "symptom_text": "The patient has no history of gastrointestinal disorders or foreign body ingestion.The patient presented with abdominal pain localized to the right lower quadrant, nausea, and vomiting. There are no respiratory symptoms or signs of asphyxiation.Abdominal X-ray revealed the presence of a radiopaque foreign body in the small intestine.Foreign body in small intestine, initial encounter. Verbatim EHR quote justifying the code: 'Abdominal X-ray confirmed the presence of a radiopaque foreign body in the small intestine.'The patient denied any history of choking episodes or inhalation of foreign objects. Physical examination findings were consistent with a localized abdominal issue.The patient was admitted for observation and scheduled for an upper endoscopy to remove the foreign body. NPO (nothing by mouth) status was initiated, and intravenous fluids were administered.The patient underwent a successful endoscopic removal of the foreign body without complications. Discharged home with instructions for a soft diet and to follow up with the gastroenterologist in two weeks.45FemaleCaucasian"
    },
    "4815": {
        "explanation_text": "Foreign body in colon, initial encounter.",
        "symptom_text": "The patient has no known history of gastrointestinal issues or foreign body ingestions.The patient presented with abdominal pain, rectal bleeding, and a history of accidentally ingesting a foreign object.Abdominal X-ray revealed the presence of a foreign body in the colon.Foreign body in colon, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with abdominal pain and rectal bleeding, imaging confirmed the presence of a foreign body in the colon.'The patient is stable and shows no signs of complications from the foreign body in the colon.Patient was scheduled for a colonoscopy to assess the foreign body and plan for its removal.Patient discharged in good condition post-colonoscopy with successful removal of the foreign body.45FemaleCaucasian"
    },
    "4816": {
        "explanation_text": "Burns involving less than 10% of body surface.",
        "symptom_text": "The patient has no history of burns or other significant medical conditions.The patient presents with redness, blistering, and pain on less than 10% of their body surface area.No significant diagnostic test results were obtained as the diagnosis was primarily clinical based on the appearance and extent of the burns.Burn involving less than 10% of body surface - The burns are superficial and limited to less than 10% of the total body surface area. The patient presents with redness, blistering, and pain on the affected areas.The patient's burns are consistent with a superficial burn involving less than 10% of their body surface area. No signs of infection or deeper tissue damage are noted.The patient was treated with topical ointments, pain management, and wound dressings. Strict wound care instructions were provided to prevent infection.The patient responded well to treatment and demonstrated good wound healing. They were discharged with instructions for wound care and follow-up in the outpatient clinic in one week.32MaleCaucasian"
    },
    "4817": {
        "explanation_text": "Adverse effect of tetracyclines, initial encounter.",
        "symptom_text": "The patient has a history of acne vulgaris and was recently started on doxycycline, a tetracycline antibiotic, for the treatment of acne.The patient presents with severe epigastric pain, nausea, vomiting, and a diffuse erythematous rash on the trunk and extremities.Laboratory tests show no electrolyte abnormalities or signs of infection. Skin biopsy reveals a drug-induced hypersensitivity reaction.Adverse effect of tetracyclines, initial encounter. The exact sentence from the EHR that justifies this code: \"The patient is diagnosed with an adverse effect of tetracyclines, presenting with gastrointestinal symptoms and a diffuse erythematous rash after initiating doxycycline therapy.\"The patient reports that symptoms started shortly after beginning the antibiotic. Physical examination shows no signs of respiratory distress or foreign body aspiration.The patient was advised to discontinue doxycycline and was prescribed antacids for symptom relief. Topical corticosteroids were recommended for the skin rash.The patient's symptoms improved with treatment, and he was discharged with instructions to avoid tetracyclines in the future.25MaleCaucasian"
    },
    "4818": {
        "explanation_text": "Underdosing of rifampicins, initial encounter.",
        "symptom_text": "The patient has a history of tuberculosis and has been prescribed rifampicin as part of the treatment regimen.The patient presents with worsening symptoms of tuberculosis despite being compliant with the prescribed rifampicin dosage.Laboratory tests show subtherapeutic levels of rifampicin in the patient's blood, indicating underdosing.Underdosing of rifampicins, initial encounter (ICD-10-CM code T366X6A): The patient is being seen due to subtherapeutic levels of rifampicin in the blood, leading to worsening symptoms of tuberculosis despite compliance with the prescribed dosage.The patient reports no adverse reactions to rifampicin. The focus is on the inefficacy of the treatment due to underdosing rather than any adverse effects.The patient's rifampicin dosage is adjusted to achieve therapeutic levels, and monitoring is scheduled to ensure the effectiveness of the treatment for tuberculosis.The patient is discharged with a revised rifampicin dosage and follow-up appointments to monitor the response to treatment.45MaleCaucasian"
    },
    "4819": {
        "explanation_text": "Adverse effect of antifungal antibiotics, systemically used, initial encounter.",
        "symptom_text": "The patient has a history of recurrent fungal infections requiring systemic antifungal treatment.The patient presents with nausea, vomiting, and a generalized rash after starting systemic antifungal antibiotics.Laboratory tests show no signs of infection but reveal elevated liver enzymes, which can be attributed to the adverse effect of antifungal antibiotics.Adverse effect of antifungal antibiotics, systemically used, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with nausea, vomiting, and rash shortly after initiating systemic antifungal antibiotics.'Patient's symptoms are consistent with an adverse reaction to antifungal antibiotics. Discontinue the current antifungal medication and initiate supportive treatment.Discontinued antifungal antibiotics. Started antihistamines for the rash and antiemetics for nausea and vomiting. Liver function will be monitored closely.56FemaleCaucasian"
    },
    "4820": {
        "explanation_text": "Adverse effect of other systemic antibiotics, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to antibiotics or adverse drug reactions.Upon taking the prescribed systemic antibiotic, the patient developed generalized urticaria, facial swelling, and mild shortness of breath.Skin prick tests were positive for the suspected antibiotic. Blood tests showed elevated IgE levels consistent with an allergic reaction.Adverse effect of other systemic antibiotics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with generalized urticaria, facial swelling, and mild shortness of breath after taking the systemic antibiotic, with positive skin prick tests and elevated IgE levels.'The patient's symptoms are consistent with an allergic reaction to the systemic antibiotic. No evidence of infection or other systemic issues.Administered antihistamines, corticosteroids, and closely monitored the patient for any signs of anaphylaxis.The patient responded well to treatment, and symptoms resolved without complications. Discharged with instructions to avoid the specific antibiotic and carry an epinephrine auto-injector for future use if needed.42FemaleCaucasian"
    },
    "4821": {
        "explanation_text": "Adverse effect of unspecified systemic antibiotic, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies to pollen but no known drug allergies. No history of adverse reactions to antibiotics.The patient presents with generalized itching, rash, and mild shortness of breath.Laboratory tests show normal complete blood count, liver function tests, and renal function tests. Allergy testing is pending.Adverse effect of unspecified systemic antibiotic, initial encounter. The patient presents with generalized itching, rash, and mild shortness of breath after taking an unspecified systemic antibiotic.The patient denies any swelling of the face, lips, or tongue. No signs of anaphylaxis. Vital signs stable. Recommend discontinuing the antibiotic and monitoring closely.Discontinuation of the antibiotic. Prescribed antihistamines for symptomatic relief. Follow-up in one week for allergy testing results.The patient responded well to treatment with resolution of itching and rash. Advised to avoid the antibiotic in the future and carry an epinephrine auto-injector due to the possibility of future allergic reactions.42FemaleCaucasian"
    },
    "4822": {
        "explanation_text": "Adverse effect of antimycobacterial drugs, initial encounter.",
        "symptom_text": "The patient has a history of latent tuberculosis infection and is currently undergoing treatment with antimycobacterial drugs.The patient presents with nausea, vomiting, and abdominal pain, which started shortly after initiating the antimycobacterial drug therapy.Liver function tests show elevated liver enzymes, specifically ALT and AST, indicating hepatotoxicity.Adverse effect of antimycobacterial drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of nausea, vomiting, and abdominal pain following the initiation of antimycobacterial drug therapy. Diagnostic tests reveal elevated liver enzymes, consistent with hepatotoxicity.'Patient reports adherence to the prescribed antimycobacterial drug regimen. Physical examination shows mild epigastric tenderness. The hepatologist has been consulted for further management.Discontinuation of the offending antimycobacterial drug. Supportive treatment with antiemetics and liver-protective agents. Close monitoring of liver function tests.The patient's symptoms improved with the cessation of the antimycobacterial drug. Liver enzymes trended down, and the patient was discharged with instructions for follow-up liver function tests in one week.56FemaleCaucasian"
    },
    "4823": {
        "explanation_text": "Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter.",
        "symptom_text": "The patient has a history of recent travel to a malaria-endemic region and was prescribed antimalarials for prophylaxis.The patient presents with nausea, vomiting, and generalized rash shortly after starting the antimalarial medication.Laboratory tests show normal electrolyte levels and liver function tests, ruling out other systemic antibiotic adverse effects.Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of nausea, vomiting, and generalized rash following the initiation of antimalarial medication.'The patient denies any other recent medication changes or exposures. Physical examination reveals no signs of respiratory distress or neurological deficits.Discontinuation of the antimalarial medication. Symptomatic treatment with antiemetics and antihistamines. Close monitoring for resolution of symptoms.Patient's symptoms improved with cessation of the antimalarial drug. Discharged home with instructions to avoid the specific antimalarial and follow up with primary care provider if symptoms recur.42FemaleCaucasian"
    },
    "4824": {
        "explanation_text": "Adverse effect of antiviral drugs, initial encounter.",
        "symptom_text": "The patient has a history of recurrent herpes simplex virus infections and is on antiviral therapy.The patient presents with nausea, vomiting, and headache after starting a new antiviral medication.Liver function tests show mild transaminitis, which could be indicative of a drug reaction.Adverse effect of antiviral drugs, initial encounter. Verbatim: 'Adverse effect of antiviral drugs, initial encounter.'Patient reports the symptoms started shortly after initiating the new antiviral medication. No other significant findings on physical examination.Discontinuation of the offending antiviral drug. Symptomatic treatment for nausea and headache. Close monitoring of liver function tests.Patient's symptoms improved after stopping the antiviral medication. Liver function tests trended down towards normal range. Patient discharged home in stable condition.45FemaleCaucasian"
    },
    "4825": {
        "explanation_text": "Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to medications, including anti-infectives and antiparasitics.The patient presents with generalized rash, itching, and mild nausea without any signs of superinfection or anaphylaxis.Laboratory tests show normal complete blood count, liver function tests, and renal function tests, ruling out systemic involvement.Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with a generalized rash and mild nausea following the recent initiation of systemic anti-infectives and antiparasitics.'The patient denies any respiratory distress, chest pain, abdominal pain, or neurological symptoms. No signs of infection or severe allergic reaction are noted upon examination.Treatment includes cessation of the offending medications, administration of antihistamines for symptomatic relief, and close monitoring for resolution of symptoms.The patient's symptoms improved significantly with the discontinuation of the medications. Discharged home with instructions to avoid the specific anti-infectives and antiparasitics that led to the adverse effects.45FemaleCaucasian"
    },
    "4826": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, initial encounter.",
        "symptom_text": "The patient has a history of asthma and was recently prescribed prednisone for an acute exacerbation of their condition.The patient presents with new-onset insomnia, increased appetite, and mild edema in the lower extremities.Laboratory tests show no electrolyte abnormalities or signs of infection.Adverse effect of glucocorticoids and synthetic analogues, initial encounter. Verbatim EHR quote justifying the code: 'Patient presenting with symptoms of insomnia, increased appetite, and mild edema after recent prednisone use.'The patient reports that the symptoms started shortly after beginning the prednisone treatment. No other new medications or significant changes in lifestyle have occurred.Discontinuation of prednisone. Symptomatic treatment for insomnia. Close monitoring of symptoms.45FemaleCaucasian"
    },
    "4827": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter.",
        "symptom_text": "The patient has a history of rheumatoid arthritis and has been on long-term prednisone therapy for the past 6 months.The patient presents with weight gain, easy bruising, and muscle weakness.Laboratory tests show elevated blood glucose levels and suppressed adrenal function.Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient with a history of long-term prednisone therapy presenting with weight gain, easy bruising, and muscle weakness, along with laboratory findings of elevated blood glucose levels and suppressed adrenal function.'The patient reports these symptoms started gradually over the past month. Physical examination reveals central obesity and purple striae on the abdomen.Discontinuation of prednisone therapy. Initiation of insulin therapy for hyperglycemia. Referral to endocrinology for further management.The patient responded well to the treatment provided and was discharged with a follow-up appointment scheduled with the endocrinologist in two weeks.49FemaleCaucasian"
    },
    "4828": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, sequela.",
        "symptom_text": "The patient has a history of asthma and was prescribed oral prednisone for an exacerbation six months ago.The patient presents with muscle weakness, easy bruising, and thinning of the skin.Laboratory tests show low cortisol levels and a DEXA scan reveals osteoporosis.Adverse effect of glucocorticoids and synthetic analogues, sequela. The patient presents with muscle weakness, easy bruising, thinning of the skin, low cortisol levels, and osteoporosis, all indicative of a sequela following glucocorticoid use.The patient reports that the symptoms started gradually after completing the prednisone course. Physical examination shows striae on the skin and proximal muscle weakness.Discontinuation of prednisone. Initiation of physical therapy for muscle weakness and referral to endocrinology for further management of adrenal insufficiency.The patient responded well to the treatment provided. Discharged with instructions for follow-up with endocrinology in two weeks.45FemaleCaucasian"
    },
    "4829": {
        "explanation_text": "Underdosing of glucocorticoids and synthetic analogues, initial encounter.",
        "symptom_text": "The patient has a history of asthma and was recently prescribed prednisone for an acute exacerbation of their symptoms.The patient presents with worsening shortness of breath, wheezing, and chest tightness despite being on a prednisone regimen.Pulmonary function tests show a decline in FEV1 compared to baseline, indicating inadequate response to glucocorticoid therapy.Underdosing of glucocorticoids and synthetic analogues, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient is presenting with worsening asthma symptoms despite being on a prednisone regimen, with pulmonary function tests showing inadequate response to glucocorticoid therapy.'The patient reports compliance with the prescribed prednisone regimen. No signs of Cushingoid features or other adverse effects of glucocorticoids noted.Increased prednisone dosage, addition of a long-acting beta-agonist inhaler, and a referral to an asthma specialist for further management.The patient responded well to the increased prednisone dosage and bronchodilator therapy. They were discharged home with close follow-up scheduled with the asthma specialist.45FemaleCaucasian"
    },
    "4830": {
        "explanation_text": "Adverse effect of thyroid hormones and substitutes, initial encounter.",
        "symptom_text": "The patient has a history of hypothyroidism and has been on levothyroxine therapy for the past 5 years.The patient presents with palpitations, sweating, and weight loss after a recent increase in levothyroxine dosage.Thyroid function tests show elevated free thyroxine (T4) levels and suppressed thyroid-stimulating hormone (TSH) levels.Adverse effect of thyroid hormones and substitutes, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of palpitations, sweating, and weight loss following a recent increase in levothyroxine dosage. Thyroid function tests reveal elevated free thyroxine (T4) levels and suppressed thyroid-stimulating hormone (TSH) levels.'Patient is responsive and alert. Vital signs are stable. No signs of cardiac arrhythmias on examination.The patient's levothyroxine dosage was reduced, and beta-blockers were prescribed to manage symptoms. Close monitoring of thyroid function tests was advised.45FemaleCaucasian"
    },
    "4831": {
        "explanation_text": "Underdosing of thyroid hormones and substitutes, initial encounter.",
        "symptom_text": "The patient has a history of hypothyroidism and has been on levothyroxine therapy for the past 5 years.The patient presents with fatigue, weight gain, cold intolerance, and dry skin.Thyroid function tests show elevated TSH levels and low free T4 levels.Underdosing of thyroid hormones and substitutes, initial encounter. Verbatim: 'This is the initial encounter for a patient with underdosing of thyroid hormones and substitutes presenting with symptoms of hypothyroidism and abnormal thyroid function tests.'The patient reports non-compliance with their levothyroxine medication due to financial constraints, leading to the current presentation of hypothyroid symptoms.The patient was educated on the importance of adherence to thyroid hormone replacement therapy and started on an appropriate dose of levothyroxine.The patient's symptoms improved with the initiation of the correct dose of levothyroxine, and they were discharged with a follow-up appointment in 4 weeks.42FemaleCaucasian"
    },
    "4832": {
        "explanation_text": "Adverse effect of antithyroid drugs, initial encounter.",
        "symptom_text": "The patient has a history of hyperthyroidism and was recently started on antithyroid medication.Presented with a rash, itching, and fever after taking antithyroid drugs.Laboratory tests show elevated liver enzymes and a decreased white blood cell count, consistent with a drug reaction.Adverse effect of antithyroid drugs, initial encounter (ICD-10-CM code T382X5A): Patient presents with a rash, itching, and fever after taking antithyroid drugs. Laboratory tests show elevated liver enzymes and decreased white blood cell count, consistent with a drug reaction.The patient reports the symptoms started shortly after beginning antithyroid medication. No other new medications or exposures reported. Suspected adverse drug reaction to antithyroid drugs.Discontinued the antithyroid medication. Started on antihistamines for the rash and itching. Liver function and blood counts will be monitored closely.Patient responded well to treatment. Rash and itching resolved, and liver enzymes started to normalize. Patient educated on potential adverse effects of antithyroid drugs and advised to avoid them in the future unless necessary.42FemaleCaucasian"
    },
    "4833": {
        "explanation_text": "Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus for the past 5 years, managed with insulin and oral hypoglycemic agents.The patient presents with dizziness, sweating, and palpitations following an increase in insulin dosage.Blood glucose levels are within the target range, ruling out hypoglycemia.Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter. Verbatim: 'This is the initial encounter for a patient who is experiencing adverse effects from insulin and oral hypoglycemic [antidiabetic] drugs.'Patient reports the symptoms started shortly after adjusting the insulin dose. No signs of infection or other systemic issues.Adjusted insulin dosage, educated patient on hypoglycemia management, advised to monitor blood glucose closely.The patient's symptoms resolved with the dosage adjustment. Discharged home with instructions for follow-up with the endocrinologist in one week.58FemaleCaucasian"
    },
    "4834": {
        "explanation_text": "Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus for the past 5 years, managed with a stable dose of insulin and oral hypoglycemic drugs.The patient presented with elevated fasting blood glucose levels, increased thirst, and frequent urination.Fasting blood glucose: 220 mg/dL, HbA1c: 8.5%, confirming poor glycemic control.Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient diagnosed with underdosing of insulin and oral hypoglycemic drugs due to poor glycemic control.'Patient reports missing doses of insulin and oral antidiabetic drugs occasionally due to forgetfulness. No signs of hypoglycemia or adverse effects observed.Adjusted insulin regimen, reinforced importance of medication adherence, and scheduled diabetic education sessions.Patient discharged in stable condition with improved blood glucose levels and scheduled follow-up in the endocrinology clinic next week.58FemaleCaucasian"
    },
    "4835": {
        "explanation_text": "Adverse effect of oral contraceptives, initial encounter.",
        "symptom_text": "The patient has been using oral contraceptives for the past year without any reported issues. No history of endocrine disorders or other medication allergies.The patient presents with nausea, vomiting, and breakthrough bleeding for the past week. Denies any fever, abdominal pain, or changes in bowel habits.Pregnancy test is negative. Complete blood count and liver function tests are within normal limits.Adverse effect of oral contraceptives, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with nausea, vomiting, and breakthrough bleeding after starting oral contraceptives.'The patient reports that symptoms started shortly after switching to a new brand of oral contraceptives. Suspected adverse reaction to the new formulation.Discontinued the current oral contraceptive brand. Prescribed antiemetics for nausea and advised on alternative contraceptive methods.25FemaleCaucasian"
    },
    "4836": {
        "explanation_text": "Underdosing of aspirin, initial encounter.",
        "symptom_text": "The patient has a history of cardiovascular disease and has been prescribed aspirin for secondary prevention.The patient presents with recurrent chest pain and palpitations.ECG shows signs of myocardial ischemia.Underdosing of aspirin, initial encounter. The patient is not taking the prescribed aspirin as per the medical advice.Patient admitted non-compliance with aspirin therapy. Underdosing of aspirin is suspected based on the recurrent symptoms and ECG findings.Initiated aspirin therapy at the appropriate dose for secondary prevention of cardiovascular events.Patient educated on the importance of adhering to aspirin therapy. Discharged with a prescription for aspirin and a follow-up appointment in two weeks.58MaleCaucasian"
    },
    "4837": {
        "explanation_text": "Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has no history of intentional self-harm or substance abuse. There is no history of thyroid disorders, diabetes, or other endocrine conditions. The patient denies the use of oral contraceptives, aspirin, propionic acid derivatives, or other NSAIDs.The patient presents with nausea, vomiting, abdominal pain, and dizziness after accidental ingestion of 4-Aminophenol derivatives.Laboratory tests show elevated liver enzymes consistent with hepatotoxicity due to 4-Aminophenol derivatives.Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient diagnosed with Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter after ingestion of the substance.'The patient's symptoms and lab results are consistent with accidental poisoning by 4-Aminophenol derivatives. No evidence of intentional overdose or adverse effects of other medications.The patient received supportive care, activated charcoal, and N-acetylcysteine for hepatoprotection.The patient responded well to treatment, and liver function tests showed improvement. The patient was discharged with instructions to follow up with a gastroenterologist for further evaluation.42FemaleCaucasian"
    },
    "4838": {
        "explanation_text": "Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and previous suicide attempts.Upon admission, the patient presented with nausea, vomiting, abdominal pain, and altered mental status.Laboratory tests showed elevated liver enzymes and metabolic acidosis consistent with poisoning by 4-Aminophenol derivatives.Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with intentional self-harm by ingestion of 4-Aminophenol derivatives leading to symptoms of nausea, vomiting, abdominal pain, and altered mental status.'The patient admitted to ingesting a large quantity of 4-Aminophenol derivatives in a suicide attempt. The clinical presentation aligns with intentional self-harm by poisoning.The patient received activated charcoal, supportive care, and was closely monitored in the intensive care unit.After stabilization and psychiatric evaluation, the patient was referred for inpatient psychiatric care.42FemaleCaucasian"
    },
    "4839": {
        "explanation_text": "Adverse effect of 4-Aminophenol derivatives, initial encounter.",
        "symptom_text": "The patient has no known allergies to medications. No history of substance abuse.The patient presents with acute onset of nausea, vomiting, and abdominal pain after taking medication containing 4-Aminophenol derivatives.Laboratory tests show elevated liver enzymes consistent with drug-induced hepatotoxicity.Adverse effect of 4-Aminophenol derivatives, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with nausea, vomiting, and elevated liver enzymes after ingestion of 4-Aminophenol derivative medication.'The patient denies any history of intentional overdose or suicide attempt. The adverse effects are in line with the known side effects of 4-Aminophenol derivatives.Discontinuation of the offending medication. Supportive care with intravenous fluids and monitoring of liver function.Patient responded well to treatment, symptoms resolved, and liver enzymes returned to normal levels. Discharged with instructions to avoid medications containing 4-Aminophenol derivatives.45FemaleCaucasian"
    },
    "4840": {
        "explanation_text": "Poisoning by propionic acid derivatives, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and was prescribed propionic acid derivatives for the treatment of a recent infection.Upon admission, the patient presented with nausea, vomiting, abdominal pain, and confusion.Blood tests revealed metabolic acidosis and elevated levels of propionic acid derivatives in the bloodstream.Poisoning by propionic acid derivatives, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with symptoms of nausea, vomiting, abdominal pain, and confusion, along with metabolic acidosis and elevated propionic acid derivative levels in the blood.'The patient admitted to ingesting a large quantity of propionic acid derivatives in a suicide attempt. The clinical presentation is consistent with intentional self-harm.The patient received gastric lavage, activated charcoal, and supportive care in the intensive care unit.After stabilization and psychiatric evaluation, the patient was transferred to the psychiatric ward for further management of underlying mental health issues.34FemaleCaucasian"
    },
    "4841": {
        "explanation_text": "Adverse effect of propionic acid derivatives, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to medications, including propionic acid derivatives. No history of previous adverse drug reactions.The patient presents with acute onset of urticaria, angioedema, and generalized pruritus shortly after taking ibuprofen, a propionic acid derivative.Skin prick test positive for ibuprofen. No other significant findings on routine blood tests.Adverse effect of propionic acid derivatives, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with urticaria, angioedema, and generalized pruritus shortly after taking ibuprofen, a propionic acid derivative.'The patient reports no prior history of similar symptoms with other medications. No signs of respiratory distress or hemodynamic instability. Diagnosis of adverse effect of propionic acid derivatives is made based on the temporal relationship between ibuprofen intake and symptom onset.Administered antihistamines for symptom relief. Advised the patient to avoid propionic acid derivatives in the future.Patient's symptoms improved with treatment, and no further complications were noted upon discharge.42FemaleCaucasian"
    },
    "4842": {
        "explanation_text": "Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter.",
        "symptom_text": "The patient has a history of osteoarthritis and occasional musculoskeletal pain. No history of oral contraceptives, androgens, or other hormones usage.The patient presents with epigastric pain, nausea, and melena after taking ibuprofen for pain relief.Laboratory tests show no signs of infection. An upper endoscopy reveals gastric erosions consistent with NSAID-induced gastritis.Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter. Verbatim EHR quote: 'Patient presents with epigastric pain, nausea, and melena after taking ibuprofen for pain relief. Endoscopy shows gastric erosions, indicating NSAID-induced gastritis.'The patient reports no known drug allergies. Discontinue ibuprofen. Start pantoprazole for gastric protection. Advise the patient to avoid NSAIDs in the future.1. Discontinuation of ibuprofen. 2. Initiation of pantoprazole 40 mg once daily for 4 weeks. 3. Symptomatic management of epigastric pain with acetaminophen.The patient's symptoms improved with treatment. Discharged with a prescription for pantoprazole and acetaminophen. Advised on NSAID avoidance and follow-up with the primary care physician in two weeks.58FemaleCaucasian"
    },
    "4843": {
        "explanation_text": "Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela.",
        "symptom_text": "The patient has a history of chronic lower back pain and has been using nonsteroidal anti-inflammatory drugs (NSAIDs) for the past five years.The patient presents with abdominal pain, melena, and fatigue.Laboratory tests show evidence of occult blood in the stool, indicating gastrointestinal bleeding.Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela. Verbatim EHR quote justifying the code: 'The patient is diagnosed with the sequela of an adverse effect of NSAIDs, presenting with gastrointestinal bleeding and fatigue.'The patient reports that the symptoms started a week ago after taking NSAIDs for back pain. Physical examination reveals tenderness in the abdomen.The patient was advised to discontinue NSAID use and was started on a proton pump inhibitor for gastric protection.The patient responded well to treatment, and symptoms resolved. Discharged with instructions to avoid NSAIDs and follow up with a gastroenterologist for further evaluation if symptoms recur.58MaleCaucasian"
    },
    "4844": {
        "explanation_text": "Adverse effect of antirheumatics, not elsewhere classified, initial encounter.",
        "symptom_text": "The patient has a history of rheumatoid arthritis and has been prescribed antirheumatic medications for the past year.The patient presents with gastrointestinal discomfort, nausea, and dizziness after taking antirheumatics.Laboratory tests show no abnormalities other than a mild elevation in liver enzymes, which is consistent with an adverse effect of antirheumatics.Adverse effect of antirheumatics, not elsewhere classified, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with gastrointestinal discomfort, nausea, and dizziness after taking antirheumatics. Laboratory tests show mild elevation in liver enzymes, consistent with adverse effect.'The patient reports that the symptoms started shortly after a recent increase in the antirheumatic medication dosage. Physical examination reveals no other significant findings.Discontinuation of the antirheumatic medication, symptomatic treatment for nausea and dizziness, and close monitoring of liver function tests.The patient responded well to the treatment, and symptoms resolved. Discharged with instructions to follow up with the rheumatologist for alternative treatment options.55FemaleCaucasian"
    },
    "4845": {
        "explanation_text": "Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to nonopioid analgesics and antipyretics.The patient presents with nausea, vomiting, and abdominal pain shortly after taking a nonopioid analgesic and antipyretic medication.Laboratory tests show no signs of liver or kidney dysfunction.Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of nausea, vomiting, and abdominal pain following the ingestion of a nonopioid analgesic and antipyretic medication. No evidence of organ dysfunction.'The patient denies any history of substance abuse or overdose. The adverse effects are consistent with the known side effects of the nonopioid analgesic and antipyretic ingested.The patient was treated symptomatically with antiemetics and intravenous fluids. The offending medication was discontinued.The patient responded well to treatment and was discharged home with instructions to avoid the specific nonopioid analgesic and antipyretic that caused the adverse effects.45FemaleCaucasian"
    },
    "4846": {
        "explanation_text": "Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter.",
        "symptom_text": "The patient has a history of occasional headaches and mild arthritis symptoms managed with over-the-counter nonopioid analgesics and antipyretics.The patient presents with mild gastrointestinal discomfort, nausea, and mild rash after taking an unspecified nonopioid analgesic, antipyretic, and antirheumatic medication.Laboratory tests show no abnormalities apart from a slightly elevated liver enzyme level possibly indicative of a mild drug reaction.Adverse effect of unspecified nonopioid analgesic, antipyretic, and antirheumatic, initial encounterThe patient reports the symptoms started shortly after taking the medication as directed. No signs of overdose or intentional poisoning are noted. The adverse effects are consistent with a mild drug reaction.The patient was advised to discontinue the medication, provided with supportive care for the gastrointestinal symptoms, and prescribed a short course of antihistamines for the rash.The patient's symptoms improved with treatment, and there were no further complications. The patient was educated on alternative pain management options and discharged in stable condition.45FemaleCaucasian"
    },
    "4847": {
        "explanation_text": "Poisoning by heroin, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of opioid use disorder and previous admissions for substance abuse treatment.The patient presented with pinpoint pupils, respiratory depression, altered mental status, and a history of heroin ingestion.Laboratory tests showed positive urine toxicology screen for opioids.Poisoning by heroin, intentional self-harm, initial encounter. The patient ingested heroin with suicidal intent.The patient admitted to ingesting a large quantity of heroin as a suicide attempt. Physical examination revealed respiratory depression and central nervous system depression consistent with opioid toxicity.The patient was treated with naloxone for opioid overdose reversal and admitted to the intensive care unit for close monitoring.The patient responded well to treatment, was psychiatrically evaluated, and transferred to the psychiatric unit for further management of suicidal ideation.32MaleCaucasian"
    },
    "4848": {
        "explanation_text": "Poisoning by other opioids, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and previous suicide attempts.The patient presents with pinpoint pupils, altered mental status, and respiratory depression.Blood tests show elevated opioid levels consistent with opioid poisoning.Poisoning by other opioids, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with altered mental status, pinpoint pupils, and a history of intentional self-harm by ingesting other opioids.'The patient admitted to ingesting a large quantity of opioids with the intent of self-harm. No evidence of accidental ingestion or adverse effects of other substances found.The patient was treated with naloxone for opioid toxicity and admitted to the intensive care unit for close monitoring.The patient responded well to treatment and was referred for psychiatric evaluation and follow-up care for depression and suicide prevention.32MaleCaucasian"
    },
    "4849": {
        "explanation_text": "Adverse effect of other opioids, initial encounter.",
        "symptom_text": "The patient has a history of chronic back pain managed with opioids.The patient presents with nausea, vomiting, dizziness, and respiratory depression after taking prescribed opioids.Lab tests show the presence of opioid metabolites in the urine.Adverse effect of other opioids, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with nausea, vomiting, dizziness, and respiratory depression following the use of prescribed opioids. Lab tests confirm the presence of opioid metabolites in the urine.'Patient reports a history of opioid use for pain management. Symptoms started shortly after adjusting the opioid dosage.Discontinuation of the opioid medication, supportive care, monitoring for respiratory status.The patient's symptoms improved with opioid cessation and supportive care. Discharged with recommendations for alternative pain management strategies.45MaleCaucasian"
    },
    "4850": {
        "explanation_text": "Poisoning by methadone, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of chronic pain management with methadone prescribed by a pain specialist for the past six months.Upon admission, the patient presented with altered mental status, pinpoint pupils, respiratory depression, and hypotension.Toxicology screening confirmed elevated methadone levels in the blood.Poisoning by methadone, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with altered mental status, pinpoint pupils, respiratory depression, and hypotension, consistent with methadone poisoning.'The patient's roommate mentioned finding an empty bottle of methadone prescribed to the patient next to the patient's bed.The patient was treated with naloxone, monitored closely in the ICU for respiratory status, and received supportive care.The patient responded well to treatment, with resolution of symptoms, and was discharged with a referral to a substance abuse program for further evaluation and management.42MaleCaucasian"
    },
    "4851": {
        "explanation_text": "Poisoning by cocaine, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and previous suicide attempts.The patient presents with tachycardia, diaphoresis, dilated pupils, and agitation.Urine toxicology screen positive for cocaine metabolites.Poisoning by cocaine, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms consistent with cocaine toxicity, confirmed by positive urine toxicology screen for cocaine metabolites.'The patient admitted to ingesting a large amount of cocaine with suicidal intent. Vital signs stable except for tachycardia. Mental status altered with signs of agitation.The patient was monitored closely in the emergency department. Administered benzodiazepines for sedation and initiated psychiatric evaluation.Patient stabilized, transferred to the psychiatric unit for further evaluation and management of suicidal ideation.32MaleCaucasian"
    },
    "4852": {
        "explanation_text": "Adverse effect of inhaled anesthetics, initial encounter.",
        "symptom_text": "The patient has no known allergies to medications, including anesthetics. No history of substance abuse or dependence. No previous adverse reactions to anesthesia.Upon exposure to inhaled anesthetics, the patient developed immediate shortness of breath, wheezing, and chest tightness. No signs of CNS depression, hallucinations, or euphoria.Pulmonary function tests revealed a significant decrease in forced expiratory volume in one second (FEV1) post-anesthesia. Blood gas analysis showed hypoxemia with a decreased partial pressure of oxygen (PaO2). Anesthetic gas chromatography confirmed the presence of inhaled anesthetics in the patient's blood.Adverse effect of inhaled anesthetics, initial encounter. Verbatim EHR quote justifying the code: 'Patient developed immediate shortness of breath, wheezing, and chest tightness post-exposure to inhaled anesthetics. Diagnostic tests revealed decreased FEV1, hypoxemia, and presence of inhaled anesthetics in blood.'The patient's symptoms are consistent with an adverse reaction to inhaled anesthetics, specifically bronchospasm and respiratory distress. No other identifiable cause for the symptoms observed.Administered oxygen therapy, bronchodilators, and corticosteroids to alleviate bronchospasm and improve oxygenation. Monitored closely for any signs of worsening respiratory distress.Patient responded well to treatment and showed improvement in respiratory function. Discharged with instructions to follow up with the pulmonologist for further evaluation of possible asthma exacerbation triggered by inhaled anesthetics.42FemaleCaucasian"
    },
    "4853": {
        "explanation_text": "Adverse effect of local anesthetics, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to medications, including local anesthetics.Upon administration of the local anesthetic, the patient developed immediate swelling, redness, and itching at the injection site. The patient also reported numbness and tingling spreading from the injection site to the surrounding area.Skin prick test for common allergens was negative. There were no signs of infection at the injection site.Adverse effect of local anesthetics, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presented with immediate swelling, redness, and itching at the injection site, along with numbness and tingling spreading from the site, consistent with an adverse effect of local anesthetics.'The patient's symptoms are localized to the injection site and are typical of an adverse reaction to the local anesthetic. No systemic symptoms or signs of anaphylaxis were observed.The patient was advised to avoid further use of the specific local anesthetic and prescribed antihistamines for symptom relief. Close monitoring for any progression of symptoms was recommended.The patient's symptoms improved with antihistamine treatment, and there were no further complications. Discharged with instructions to seek immediate medical attention if any new symptoms develop.42FemaleCaucasian"
    },
    "4854": {
        "explanation_text": "Adverse effect of unspecified anesthetic, initial encounter.",
        "symptom_text": "The patient has no known history of adverse reactions to anesthetics or other substances.Upon administration of the unspecified anesthetic, the patient developed localized redness and swelling at the injection site, accompanied by mild itching. The patient reported no systemic symptoms such as dizziness, palpitations, or respiratory distress.No abnormal findings on physical examination or laboratory tests, ruling out specific toxic effects of other substances.Adverse effect of unspecified anesthetic, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with localized redness, swelling, and itching at the injection site following administration of an unspecified anesthetic.'The patient is stable and responsive, with no signs of systemic toxicity. The localized symptoms are consistent with a mild allergic reaction to the anesthetic.Administered antihistamines and topical corticosteroids to alleviate the local allergic reaction. The patient was monitored for any progression of symptoms.The patient responded well to treatment, with resolution of redness and swelling. Advised the patient to avoid the specific anesthetic in the future and provided guidance on alternative options if needed.42FemaleCaucasian"
    },
    "4855": {
        "explanation_text": "Adverse effect of hydantoin derivatives, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and has been on phenytoin for seizure control.The patient presents with nystagmus, dizziness, and diplopia.Serum phenytoin levels are elevated.Adverse effect of hydantoin derivatives, initial encounter. The patient presents with nystagmus, dizziness, and diplopia, consistent with phenytoin toxicity.The patient's symptoms are indicative of an adverse effect of phenytoin. Discontinuation of phenytoin and close monitoring are recommended.Discontinuation of phenytoin. Initiation of supportive care and symptomatic treatment.The patient's symptoms improved with discontinuation of phenytoin. The patient was discharged home with close follow-up.45FemaleCaucasian"
    },
    "4856": {
        "explanation_text": "Adverse effect of iminostilbenes, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to medications, including iminostilbenes.The patient presents with symptoms of dizziness, nausea, and skin rash shortly after taking iminostilbenes.Laboratory tests show no abnormalities except for a slightly elevated liver enzyme level, which is consistent with iminostilbenes' known side effects.Adverse effect of iminostilbenes, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dizziness, nausea, and skin rash following the ingestion of iminostilbenes.'The physician notes that the patient's symptoms are in line with the expected adverse effects of iminostilbenes and recommends discontinuing the medication.The patient was advised to stop taking iminostilbenes and was prescribed antihistamines for the skin rash. Close monitoring of symptoms was recommended.The patient's symptoms improved with the cessation of iminostilbenes and antihistamine treatment. The patient was discharged in stable condition with instructions to avoid iminostilbenes in the future.45FemaleCaucasian"
    },
    "4857": {
        "explanation_text": "Adverse effect of barbiturates, initial encounter.",
        "symptom_text": "The patient has no known history of substance abuse or dependence. No history of allergies to barbiturates or other medications.The patient presents with drowsiness, confusion, and slurred speech after taking a barbiturate for the first time.Blood tests show no signs of infection or other abnormalities. Toxicology screening confirms the presence of barbiturates in the patient's system.Adverse effect of barbiturates, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with drowsiness, confusion, and slurred speech after taking a barbiturate for the first time.'The patient's vital signs are stable. No signs of respiratory depression or other serious complications related to barbiturate use.Patient was monitored closely in the emergency department. Supportive care provided, including intravenous fluids and observation.Patient's symptoms improved with observation. Discharged with advice to avoid barbiturates and follow up with their primary care physician if any concerns arise.45MaleCaucasian"
    },
    "4858": {
        "explanation_text": "Poisoning by benzodiazepines, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of anxiety and occasional insomnia for which benzodiazepines were prescribed.The patient presented with drowsiness, confusion, slurred speech, and ataxia.Toxicology screening showed elevated levels of benzodiazepines in the blood.Poisoning by benzodiazepines, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with drowsiness, confusion, slurred speech, and ataxia, toxicology screening revealed elevated benzodiazepine levels.'The patient's symptoms are consistent with benzodiazepine poisoning. No evidence of intentional self-harm or use of other substances.The patient was treated with activated charcoal, close monitoring, and supportive care.The patient's symptoms improved, and after psychiatric evaluation, no suicidal ideation was noted. Discharged with a follow-up plan.45FemaleCaucasian"
    },
    "4859": {
        "explanation_text": "Adverse effect of benzodiazepines, initial encounter.",
        "symptom_text": "The patient has a history of anxiety disorder for which benzodiazepines were prescribed.The patient presents with drowsiness, confusion, and slurred speech.Blood tests show no abnormalities. Urine toxicology screen is positive for benzodiazepines.Adverse effect of benzodiazepines, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with drowsiness, confusion, and slurred speech, consistent with an adverse effect of benzodiazepines. Urine toxicology screen positive for benzodiazepines.'Patient's symptoms are in line with a known adverse effect profile of benzodiazepines. No other apparent cause for the symptoms identified.Discontinuation of benzodiazepines. Supportive care and monitoring for symptom resolution.Patient's symptoms improved with discontinuation of benzodiazepines. Discharged home with instructions for follow-up with primary care physician.45FemaleCaucasian"
    },
    "4860": {
        "explanation_text": "Underdosing of benzodiazepines, initial encounter.",
        "symptom_text": "The patient has a history of anxiety and insomnia for which benzodiazepines were prescribed.The patient presents with increased anxiety, persistent insomnia, and agitation despite being on benzodiazepine therapy.Lab tests indicate subtherapeutic levels of benzodiazepines in the patient's blood.Underdosing of benzodiazepines, initial encounter. Verbatim from ICD-10-CM: 'This code is for use as the initial encounter for a patient who is underdosed with benzodiazepines.'Patient reports poor response to current benzodiazepine therapy despite compliance. No signs of benzodiazepine overdose or toxicity observed.Increased dosage of benzodiazepines as per physician's recommendation to achieve therapeutic levels.Patient discharged in stable condition with close follow-up to monitor response to adjusted benzodiazepine therapy.45MaleCaucasian"
    },
    "4861": {
        "explanation_text": "Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and has been prescribed antiepileptic medications for the past five years. No history of substance abuse or intentional overdose.The patient presented with drowsiness, confusion, and slurred speech. No signs of self-harm or suicidal ideation.Blood tests showed elevated levels of antiepileptic drugs in the system. No abnormalities in liver function tests.Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Accidental poisoning by antiepileptic and sedative-hypnotic drugs.'Patient's caregiver mentioned an unintentional double dose of the antiepileptic medication. No evidence of deliberate overdose.The patient was monitored closely, and supportive care was provided. The antiepileptic medication dosage was adjusted.The patient's symptoms improved, and there were no further complications. Patient educated on the importance of medication adherence and proper dosing.42MaleCaucasian"
    },
    "4862": {
        "explanation_text": "Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and anxiety disorder, for which they have been prescribed antiepileptic and sedative-hypnotic medications.The patient presents with increased seizure frequency and heightened anxiety despite compliance with their prescribed medication regimen.EEG shows abnormal brain activity consistent with increased seizure risk.Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient's increased seizure frequency and heightened anxiety are indicative of underdosing of their antiepileptic and sedative-hypnotic medications.'Patient reports diligently taking their medications as prescribed but experiencing breakthrough seizures and worsening anxiety symptoms.Adjusted the dosage of the current antiepileptic and sedative-hypnotic medications and scheduled a follow-up visit to monitor the response.42FemaleCaucasian"
    },
    "4863": {
        "explanation_text": "Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and anxiety disorder for which they have been prescribed antiepileptic and sedative-hypnotic medications.The patient presents with dizziness, drowsiness, and confusion.The comprehensive metabolic panel and complete blood count are within normal limits. EEG shows no epileptiform discharges.Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter. The patient presents with dizziness, drowsiness, and confusion, consistent with the adverse effects of these medications.The patient reports the symptoms started shortly after a recent change in their medication regimen. No signs of drug abuse or intentional overdose are noted. The patient is responsive but appears lethargic.The patient was advised to discontinue the suspected medications. Supportive care and close monitoring for symptom resolution were recommended. No specific antidote is available for this adverse effect.The patient's symptoms improved with discontinuation of the medications. They were discharged with instructions to follow up with their primary care physician for medication adjustment.45FemaleCaucasian"
    },
    "4864": {
        "explanation_text": "Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter.",
        "symptom_text": "The patient has a history of Parkinson's disease and has been prescribed antiparkinsonism drugs and central muscle-tone depressants due to muscle rigidity and tremors.The patient presents with increased drowsiness, dizziness, and blurred vision after the recent adjustment in antiparkinsonism medication dosage.No specific diagnostic tests were performed as the symptoms are consistent with the known adverse effects of the prescribed medications.Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with increased drowsiness, dizziness, and blurred vision after the recent adjustment in antiparkinsonism medication dosage.'Patient reports no other significant changes in medication or lifestyle. Vital signs stable. Neurological examination shows no focal deficits.Discontinuation of the recent adjustment in antiparkinsonism medication dosage. Symptomatic treatment for dizziness and blurred vision. Close monitoring of medication side effects.Patient responded well to the treatment provided. Symptoms of dizziness and blurred vision resolved. Patient educated on the importance of gradual dosage adjustments and to report any new or worsening symptoms promptly.68MaleCaucasian"
    },
    "4865": {
        "explanation_text": "Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and was prescribed tricyclic antidepressants for the past year.Upon arrival, the patient presented with altered mental status, dry skin, dilated pupils, and tachycardia.ECG showed a widened QRS complex. Blood gas analysis revealed metabolic acidosis. Serum tricyclic antidepressant levels were elevated.Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted after intentional ingestion of tricyclic antidepressants leading to altered mental status, tachycardia, and anticholinergic symptoms.'The patient admitted to ingesting a large quantity of tricyclic antidepressants with suicidal intent. Close monitoring for cardiac complications was initiated.The patient received activated charcoal, intravenous sodium bicarbonate for QRS prolongation, and was placed on continuous cardiac monitoring.The patient's condition stabilized post-treatment, and arrangements were made for outpatient psychiatric follow-up.42FemaleCaucasian"
    },
    "4866": {
        "explanation_text": "Adverse effect of tricyclic antidepressants, initial encounter.",
        "symptom_text": "The patient has a history of depression and was recently started on tricyclic antidepressants for the first time.The patient presents with dizziness, dry mouth, blurred vision, and urinary retention.ECG shows a prolonged QT interval, which is a known adverse effect of tricyclic antidepressants.Adverse effect of tricyclic antidepressants, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dizziness, dry mouth, blurred vision, and urinary retention after starting tricyclic antidepressants.'The patient's symptoms are consistent with the known side effects of tricyclic antidepressants. Discontinuation of the medication is recommended.Discontinuation of tricyclic antidepressants. Supportive care with hydration and monitoring of vital signs.The patient's symptoms improved after stopping the tricyclic antidepressants. Discharged with instructions to follow up with a psychiatrist for alternative treatment options.45FemaleCaucasian"
    },
    "4867": {
        "explanation_text": "Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed selective serotonin and norepinephrine reuptake inhibitors.The patient presented with altered mental status, confusion, tachycardia, and nausea, indicating a toxic reaction to the selective serotonin and norepinephrine reuptake inhibitors.Blood tests showed elevated levels of the specific medications in the patient's system, confirming the poisoning.Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted after intentional ingestion of selective serotonin and norepinephrine reuptake inhibitors resulting in toxic effects.'The patient admitted to taking a higher dose of their prescribed medication with the intent of self-harm. No evidence of accidental ingestion or underdosing was found.The patient was treated with activated charcoal, monitored closely in the intensive care unit, and received supportive care to manage symptoms and stabilize vitals.Following stabilization and psychiatric evaluation, the patient was referred to outpatient mental health services for further management of their underlying depression and suicidal ideation.42MaleCaucasian"
    },
    "4868": {
        "explanation_text": "Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety disorders for which selective serotonin and norepinephrine reuptake inhibitors were prescribed.The patient presents with nausea, dizziness, and excessive sweating after starting the new medication.Laboratory tests show no abnormalities, ruling out other potential causes for the symptoms.Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of nausea, dizziness, and excessive sweating shortly after initiating selective serotonin and norepinephrine reuptake inhibitors.'The patient denies any history of intentional overdose or underdosing of medications. The symptoms are consistent with known adverse effects of the prescribed medication.Discontinuation of the selective serotonin and norepinephrine reuptake inhibitors. Symptomatic treatment for nausea and dizziness.The patient's symptoms improved after discontinuing the medication. Advised to follow up with the prescribing physician for alternative treatment options.45FemaleCaucasian"
    },
    "4869": {
        "explanation_text": "Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety disorders for which selective serotonin and norepinephrine reuptake inhibitors were prescribed.The patient presents with worsening depressive symptoms, including persistent sadness, fatigue, and decreased interest in daily activities.Laboratory tests show normal electrolyte levels and liver function tests. A urine drug screen is negative for illicit substances.Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with worsening depressive symptoms and a history of depression and anxiety disorders for which selective serotonin and norepinephrine reuptake inhibitors were prescribed.'The patient denies any suicidal ideation or intent. Physical examination is unremarkable except for psychomotor retardation.The patient's medication regimen of selective serotonin and norepinephrine reuptake inhibitors is being optimized with close monitoring of symptoms and side effects.The patient responded well to the treatment plan and was discharged with instructions for follow-up with the psychiatrist in two weeks.42FemaleCaucasian"
    },
    "4870": {
        "explanation_text": "Adverse effect of selective serotonin reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which selective serotonin reuptake inhibitors were prescribed.The patient presents with nausea, dizziness, and excessive sweating.Laboratory tests show no abnormalities; ECG is within normal limits.Adverse effect of selective serotonin reuptake inhibitors, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with nausea, dizziness, and excessive sweating after the recent initiation of selective serotonin reuptake inhibitors.'The patient denies any suicidal ideation or self-harm behaviors. Symptoms are consistent with an adverse reaction to the prescribed medication.Discontinuation of the selective serotonin reuptake inhibitors. Symptomatic treatment with antiemetics and hydration.Patient responded well to the treatment, symptoms resolved, and the patient was discharged home with instructions to follow up with their primary care physician.42FemaleCaucasian"
    },
    "4871": {
        "explanation_text": "Underdosing of selective serotonin reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety disorders for which selective serotonin reuptake inhibitors were prescribed.The patient presents with worsening depressive symptoms, increased anxiety, and sleep disturbances.Laboratory tests show subtherapeutic levels of the prescribed selective serotonin reuptake inhibitor.Underdosing of selective serotonin reuptake inhibitors, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient is underdosed with selective serotonin reuptake inhibitors, leading to worsening depressive symptoms and subtherapeutic drug levels.'The physician notes the importance of optimizing the dosage of the selective serotonin reuptake inhibitor to achieve therapeutic effects.The patient's medication dosage is adjusted, and psychotherapy sessions are scheduled to address the worsening symptoms.The patient is discharged with a follow-up appointment in two weeks to monitor the treatment response.42FemaleCaucasian"
    },
    "4872": {
        "explanation_text": "Poisoning by other antidepressants, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed antidepressants. There is a documented history of intentional self-harm by overdose in the past.The patient presents with altered mental status, dizziness, nausea, vomiting, and tachycardia. There are no extrapyramidal symptoms, hallucinations, or other neurological deficits.Serum drug levels confirm toxic levels of an antidepressant. ECG shows sinus tachycardia without any conduction abnormalities.Poisoning by other antidepressants, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with altered mental status, nausea, vomiting, and tachycardia. Serum drug levels confirm toxic levels of an antidepressant.'The patient admitted to taking an overdose of their prescribed antidepressant in a suicide attempt. No signs of extrapyramidal symptoms or hallucinations noted. The patient is closely monitored for cardiac complications due to the overdose.The patient received activated charcoal, intravenous fluids, and close cardiac monitoring. Psychiatric consultation was requested for further evaluation and management of the underlying mental health condition.The patient's condition improved with treatment, and they were discharged with a referral to outpatient psychiatric follow-up for ongoing care and management of their mental health condition.42FemaleCaucasian"
    },
    "4873": {
        "explanation_text": "Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been on phenothiazine antipsychotic medication for the past two years.The patient presents with acute dystonia, muscle stiffness, tremors, and akathisia after a recent increase in the dosage of their antipsychotic medication.Blood tests show normal electrolyte levels and no signs of infection. A CT scan of the brain is unremarkable.Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with acute dystonia, muscle stiffness, tremors, and akathisia after recent dosage adjustment of phenothiazine antipsychotic medication.'The patient's symptoms are consistent with an adverse reaction to phenothiazine antipsychotics. No signs of other drug ingestion or substance abuse are noted.The patient was administered diphenhydramine for acute dystonia and benztropine for muscle stiffness. The antipsychotic medication dosage was reduced.The patient's symptoms improved with treatment, and they were discharged with a follow-up appointment scheduled in one week.42MaleCaucasian"
    },
    "4874": {
        "explanation_text": "Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been prescribed antipsychotic medications in the past.The patient presents with drowsiness, confusion, and extrapyramidal symptoms such as tremors and muscle rigidity.Blood tests confirm the presence of the specific antipsychotic substance in the patient's system.Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted due to accidental poisoning by other antipsychotics and neuroleptics.'The patient appears somnolent but responsive. No signs of deliberate self-harm are noted. Accidental ingestion of the antipsychotic medication is confirmed by the patient's family.The patient is being treated with activated charcoal and supportive care to manage the symptoms of poisoning.The patient's condition improved with treatment, and arrangements have been made for outpatient follow-up.42FemaleCaucasian"
    },
    "4875": {
        "explanation_text": "Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed antipsychotic medication.The patient presents with drowsiness, confusion, slurred speech, and self-inflicted lacerations on the wrists.Toxicology screening shows elevated levels of antipsychotic medication in the blood.Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with self-inflicted lacerations and toxic levels of antipsychotic medication in the blood.'The patient admitted to intentionally harming themselves by overdosing on their antipsychotic medication. Physical examination reveals lacerations on the wrists. Toxicology results confirm elevated levels of antipsychotics in the bloodstream.The patient was started on activated charcoal to absorb the remaining medication in the stomach. Psychiatric consultation was requested for further evaluation and management of the underlying mental health condition.The patient's condition stabilized, and they were referred to outpatient psychiatric follow-up for ongoing care and management of their mental health concerns.32FemaleCaucasian"
    },
    "4876": {
        "explanation_text": "Adverse effect of other antipsychotics and neuroleptics, initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been on antipsychotic medication for the past five years without any adverse effects reported.The patient presented with acute dystonia, characterized by sustained muscle contractions, resulting in abnormal postures.No significant abnormalities were noted in the comprehensive metabolic panel and complete blood count.Adverse effect of other antipsychotics and neuroleptics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with acute dystonia after recent initiation of a new antipsychotic medication.'The patient's symptoms are consistent with acute dystonia, a known adverse effect of antipsychotic medications.The patient was treated with intramuscular diphenhydramine, resulting in the resolution of acute dystonia.The patient was observed for 24 hours post-treatment with stable vital signs and no recurrence of dystonic symptoms. Discharged home with instructions to follow up with the psychiatrist in one week.38MaleCaucasian"
    },
    "4877": {
        "explanation_text": "Underdosing of other antipsychotics and neuroleptics, initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been prescribed antipsychotic medications in the past.The patient is presenting with exacerbation of psychotic symptoms such as hallucinations and delusions.Laboratory tests show therapeutic levels of the prescribed antipsychotic medication, confirming adherence to the treatment plan.Underdosing of other antipsychotics and neuroleptics, initial encounter. Verbatim: 'Underdosing of other antipsychotics and neuroleptics, initial encounter.'The patient reports missing multiple doses of their antipsychotic medication due to forgetfulness. This non-adherence has led to the exacerbation of psychotic symptoms.The patient has been counseled on the importance of medication adherence. A new dosing schedule has been provided, and close monitoring of symptoms has been recommended.The patient is stable and has agreed to follow the new medication regimen. Discharged with a follow-up appointment in two weeks to assess treatment response.42MaleCaucasian"
    },
    "4878": {
        "explanation_text": "Poisoning by amphetamines, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has no known history of substance abuse or psychiatric disorders. No previous incidents of intentional self-harm or suicide attempts.The patient presented with agitation, tachycardia, diaphoresis, and mydriasis. Denies any suicidal ideation or intention to harm oneself. No signs of psychosis or hallucinations observed.Urine toxicology screen positive for amphetamines. Electrocardiogram (ECG) showed sinus tachycardia. Blood tests revealed no electrolyte abnormalities.Poisoning by amphetamines, accidental (unintentional), initial encounter. Verbatim quote from ICD-10-CM: 'This code is to be used when a patient suffers an accidental poisoning due to the ingestion of amphetamines.'Patient denies any history of intentional amphetamine use. Symptoms are consistent with acute amphetamine toxicity. No evidence of suicidal behavior or intent. Recommending close monitoring and supportive care.The patient was managed with intravenous fluids for hydration and benzodiazepines for agitation control. Continuous cardiac monitoring initiated. Psychiatric consultation scheduled for further evaluation post-discharge.The patient's symptoms improved during hospitalization. Discharged in stable condition with instructions to follow up with the psychiatric team. Advised on the risks of amphetamine use and encouraged to seek help if needed.32MaleCaucasian"
    },
    "4879": {
        "explanation_text": "Poisoning by amphetamines, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and recent episodes of deliberate self-harm.The patient presents with tachycardia, diaphoresis, agitation, and mydriasis.Urinalysis confirms the presence of amphetamines in the patient's system.Poisoning by amphetamines, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of amphetamine poisoning following intentional ingestion in the setting of a history of depression and deliberate self-harm.'The patient admitted to ingesting a large quantity of amphetamines with suicidal intent. Mental health evaluation reveals underlying depression and suicidal ideation.The patient received activated charcoal, intravenous fluids, and psychiatric consultation for suicide risk assessment.The patient's condition stabilized, and arrangements were made for psychiatric follow-up post-discharge.32FemaleCaucasian"
    },
    "4880": {
        "explanation_text": "Adverse effect of amphetamines, initial encounter.",
        "symptom_text": "The patient has a history of attention deficit hyperactivity disorder (ADHD) for which they have been prescribed amphetamines.The patient presents with tachycardia, hypertension, diaphoresis, and agitation.Urine toxicology screening is positive for amphetamines.Adverse effect of amphetamines, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with tachycardia, hypertension, diaphoresis, and agitation along with a positive urine toxicology screening for amphetamines.'The patient's symptoms are consistent with an adverse effect of amphetamines. The patient reports taking their prescribed dose of amphetamines without any recent changes in the medication regimen. Cessation of amphetamines is recommended, and the patient will be closely monitored for symptom resolution.The patient was advised to discontinue the use of amphetamines. Supportive care was provided to manage symptoms, including rest and hydration.32MaleCaucasian"
    },
    "4881": {
        "explanation_text": "Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional heartburn, but no history of substance abuse or intentional self-harm.Upon arrival, the patient presented with dry mouth, blurred vision, urinary retention, tachycardia, and confusion.Blood tests showed elevated levels of specific anticholinergic substances. ECG revealed sinus tachycardia.Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with symptoms of dry mouth, blurred vision, urinary retention, tachycardia, and confusion, consistent with accidental poisoning by parasympatholytics and spasmolytics.'The patient's family confirmed the accidental ingestion of medication prescribed for irritable bowel syndrome by a family member with a similar medication container. The patient was responsive but disoriented upon arrival.The patient received supportive care including intravenous fluids, activated charcoal, and close monitoring of vital signs. Physostigmine, a cholinesterase inhibitor, was administered to reverse the anticholinergic effects.The patient's symptoms improved significantly with treatment, and after ensuring no residual effects, the patient was discharged with instructions to avoid the ingested medication and follow up with their primary care physician for further monitoring.42FemaleCaucasian"
    },
    "4882": {
        "explanation_text": "Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter.",
        "symptom_text": "The patient has a history of irritable bowel syndrome and seasonal allergies.The patient presents with dry mouth, blurred vision, urinary retention, and constipation.Laboratory tests show no abnormalities.Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dry mouth, blurred vision, urinary retention, and constipation, consistent with the adverse effects of anticholinergic medications.'The physician notes the presence of classic anticholinergic symptoms and confirms the recent initiation of a new anticholinergic medication for the patient's irritable bowel syndrome.The patient was advised to stop the newly prescribed medication and was given supportive care to manage the symptoms.The patient's symptoms improved with discontinuation of the medication, and they were discharged home in stable condition.45FemaleCaucasian"
    },
    "4883": {
        "explanation_text": "Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter.",
        "symptom_text": "The patient has a history of irritable bowel syndrome and anxiety disorder, for which they have been prescribed anticholinergics and spasmolytics.The patient presents with increased gastrointestinal motility, urinary retention, and blurred vision.Urinalysis shows no signs of infection. Colonoscopy is scheduled to evaluate the gastrointestinal symptoms.Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter. Verbatim EHR quote justifying the code: 'The patient's symptoms and medical history are consistent with the underdosing of anticholinergics and spasmolytics.'The patient reports non-compliance with their prescribed anticholinergic and spasmolytic medications due to concerns about side effects. Plan to educate the patient on the importance of medication adherence and to adjust the treatment regimen.The patient will be started on a lower dose of anticholinergics and spasmolytics to improve tolerance. Follow-up scheduled in two weeks to assess the response to the adjusted medication regimen.45FemaleCaucasian"
    },
    "4884": {
        "explanation_text": "Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter.",
        "symptom_text": "The patient has a history of hypertension and has been prescribed alpha-adrenoreceptor agonists for the past six months.The patient presents with severe headaches, dizziness, and palpitations.Blood pressure reading shows elevated blood pressure of 160/100 mmHg.Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of severe headaches, dizziness, and palpitations, consistent with the adverse effects of predominantly alpha-adrenoreceptor agonists.'Patient's symptoms are likely due to the alpha-adrenoreceptor agonists' side effects. Discontinue current medication and monitor closely.Discontinued alpha-adrenoreceptor agonists. Prescribed alternative antihypertensive medication. Advised lifestyle modifications.Patient's symptoms improved after discontinuation of the alpha-adrenoreceptor agonists. Blood pressure stabilized, and the patient was discharged with follow-up instructions.58MaleCaucasian"
    },
    "4885": {
        "explanation_text": "Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter.",
        "symptom_text": "The patient has a history of asthma and has been prescribed a beta-adrenoreceptor agonist inhaler for symptom control.The patient presents with palpitations, tremors, and mild anxiety. No signs of alpha-adrenoreceptor agonist effects like orthostatic hypotension or dizziness are reported.ECG shows sinus tachycardia without any conduction abnormalities. Blood pressure within normal limits.Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with palpitations, tremors, and mild anxiety after using a beta-adrenoreceptor agonist inhaler for asthma.'Patient denies any chest pain, shortness of breath, or syncope. No other significant findings on physical examination.Discontinue the beta-adrenoreceptor agonist inhaler. Prescribe a short-acting bronchodilator for asthma symptoms. Advise the patient on alternative asthma management strategies.Patient's symptoms improved after discontinuing the beta-adrenoreceptor agonist. Educated the patient on the importance of reporting adverse effects of medications promptly.45FemaleCaucasian"
    },
    "4886": {
        "explanation_text": "Adverse effect of alpha-adrenoreceptor antagonists, initial encounter.",
        "symptom_text": "The patient has a history of hypertension for which they were prescribed alpha-adrenoreceptor antagonists.The patient presents with dizziness, orthostatic hypotension, and fatigue.Blood pressure readings showing postural hypotension.Adverse effect of alpha-adrenoreceptor antagonists, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with dizziness, orthostatic hypotension, and fatigue, consistent with the adverse effects of alpha-adrenoreceptor antagonists.'Patient's symptoms are in line with the known adverse effects of alpha-adrenoreceptor antagonists. No other apparent causes for the symptoms.Discontinuation of the alpha-adrenoreceptor antagonist medication. Introduction of alternative antihypertensive therapy.Patient's symptoms improved with the change in medication. Advised on lifestyle modifications to manage hypertension.58MaleCaucasian"
    },
    "4887": {
        "explanation_text": "Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and previous suicide attempts.Upon arrival, the patient presented with bradycardia, hypotension, and altered mental status.ECG showed prolonged QT interval. Blood tests revealed elevated levels of beta-adrenoreceptor antagonists.Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted to intentionally ingesting beta-adrenoreceptor antagonists with clear suicidal intent, presenting with typical symptoms of beta-blocker toxicity.'The patient admitted to ingesting a large quantity of beta-blockers in a suicide attempt. Physical examination and diagnostic tests support the diagnosis of beta-blocker poisoning.The patient was treated with activated charcoal, intravenous fluids, and atropine. Close monitoring of vital signs and continuous ECG monitoring was initiated.Following treatment, the patient's condition improved, and psychiatric evaluation was recommended for further management of the underlying mental health issues.42FemaleCaucasian"
    },
    "4888": {
        "explanation_text": "Adverse effect of beta-adrenoreceptor antagonists, initial encounter.",
        "symptom_text": "The patient has a history of hypertension for which beta-adrenoreceptor antagonists were prescribed.The patient presents with bradycardia, hypotension, and dizziness.ECG shows sinus bradycardia with a heart rate of 50 bpm.Adverse effect of beta-adrenoreceptor antagonists, initial encounter. Verbatim EHR quote justifying the code: 'Patient presenting with bradycardia, hypotension, and dizziness after taking beta-adrenoreceptor antagonists.'The patient reports that the symptoms started shortly after taking the first dose of the beta-blocker.Discontinuation of the beta-blocker, intravenous fluids, and close monitoring of vital signs.The patient's symptoms resolved with supportive care, and they were discharged with instructions to avoid beta-blockers in the future.58MaleCaucasian"
    },
    "4889": {
        "explanation_text": "Underdosing of beta-adrenoreceptor antagonists, initial encounter.",
        "symptom_text": "The patient has a history of hypertension and atrial fibrillation managed with beta blockers.The patient presents with increased heart rate, palpitations, and dizziness.ECG shows sinus tachycardia. Blood tests indicate subtherapeutic levels of beta blocker in the system.Underdosing of beta-adrenoreceptor antagonists, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with symptoms consistent with underdosing of beta blockers, confirmed by subtherapeutic levels of the medication in the blood.'Patient reports forgetting to take their beta blocker medication for the past week due to a busy schedule. No signs of intentional self-harm or overdose.Initiated education on the importance of medication adherence. Restarted beta blocker therapy at a lower dose with close monitoring.Patient educated on the significance of regular medication intake and advised on follow-up with the primary care physician for dose adjustments and monitoring.65MaleCaucasian"
    },
    "4890": {
        "explanation_text": "Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional motion sickness for which antiallergic and antiemetic medications were prescribed.The patient presented with dizziness, drowsiness, nausea, and vomiting after taking antiallergic and antiemetic drugs.Blood tests showed elevated levels of the specific antiallergic and antiemetic drugs in the patient's system.Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of dizziness, drowsiness, nausea, and vomiting after ingestion of antiallergic and antiemetic drugs. Lab tests confirm elevated levels of these drugs.'Patient admitted to taking a higher dose of antiallergic and antiemetic drugs than prescribed accidentally. No evidence of intentional self-harm or adverse effects of other drug classes.The patient was treated with activated charcoal, intravenous fluids, and close monitoring in the hospital.Patient's symptoms improved with treatment, and no further complications were observed upon discharge.45FemaleCaucasian"
    },
    "4891": {
        "explanation_text": "Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional nausea for which antiallergic and antiemetic drugs were prescribed.The patient presents with drowsiness, confusion, and reports of ingesting a large quantity of antiallergic and antiemetic drugs.Blood tests show elevated levels of the specific antiallergic and antiemetic drugs in the bloodstream.Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient ingested a large quantity of antiallergic and antiemetic drugs with the intent of self-harm.'The patient admitted to intentionally consuming the antiallergic and antiemetic drugs. No signs of underdosing or adverse effects of other drug classes were noted.The patient was monitored closely, received activated charcoal, and was started on supportive care.After observation and symptomatic treatment, the patient's condition improved, and psychiatric evaluation was recommended for further management.32MaleCaucasian"
    },
    "4892": {
        "explanation_text": "Adverse effect of antiallergic and antiemetic drugs, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional episodes of nausea and vomiting for which antiallergic and antiemetic drugs were prescribed in the past.The patient presents with dizziness, itching, and mild rash shortly after taking antiallergic and antiemetic medications.Laboratory tests show no abnormalities other than a slightly elevated eosinophil count, which can be attributed to the allergic reaction.Adverse effect of antiallergic and antiemetic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of dizziness, itching, and mild rash shortly after taking antiallergic and antiemetic medications.'The physician notes that the symptoms align with a known adverse effect profile of the prescribed antiallergic and antiemetic drugs.The patient was advised to discontinue the antiallergic and antiemetic medications, prescribed antihistamines for symptom relief, and instructed to follow up if symptoms persist or worsen.42FemaleCaucasian"
    },
    "4893": {
        "explanation_text": "Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of breast cancer and is currently undergoing chemotherapy with antineoplastic drugs.The patient presented with nausea, vomiting, and dizziness following the most recent chemotherapy session.Laboratory tests revealed elevated levels of the specific antineoplastic drug in the patient's blood.Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter. Verbatim ICD-10-CM justification: 'This code is used for an initial encounter for accidental poisoning by antineoplastic and immunosuppressive drugs.'The physician documented that the patient inadvertently took a higher dose of the prescribed antineoplastic drug, leading to the symptoms of poisoning.The patient was treated with supportive care, including intravenous fluids and antiemetic medication to alleviate the symptoms.The patient's symptoms resolved with treatment, and they were discharged with instructions for close monitoring and dose adjustments for future chemotherapy sessions.54FemaleCaucasian"
    },
    "4894": {
        "explanation_text": "Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter.",
        "symptom_text": "The patient has a history of breast cancer and is currently undergoing chemotherapy with antineoplastic drugs. No history of allergies to medications or previous adverse drug reactions.The patient presents with nausea, vomiting, and fatigue following the recent administration of chemotherapy. No signs of bleeding, thrombosis, or cardiovascular symptoms.Laboratory tests show mild leukopenia and elevated liver enzymes, consistent with the known side effects of the prescribed antineoplastic drugs.Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presenting with symptoms of nausea, vomiting, and fatigue after recent chemotherapy administration, along with laboratory findings of mild leukopenia and elevated liver enzymes, indicative of adverse effects of antineoplastic drugs.'Patient's symptoms started shortly after the chemotherapy session. No signs of infection or other complications. The patient is hemodynamically stable with no acute distress.Initiated antiemetic therapy for nausea and vomiting. Increased hydration and close monitoring of liver function tests. Chemotherapy regimen adjusted for the next cycle.The patient responded well to the antiemetic therapy and supportive care. Liver enzymes trended down, and leukopenia improved. Discharged home with instructions for follow-up blood work and scheduled chemotherapy sessions.58 yearsFemaleCaucasian"
    },
    "4895": {
        "explanation_text": "Adverse effect of antineoplastic and immunosuppressive drugs, sequela.",
        "symptom_text": "The patient has a history of breast cancer and has been on antineoplastic and immunosuppressive drugs for the past year.The patient presents with fatigue, easy bruising, and petechiae.Hematological tests show thrombocytopenia and anemia, which are consistent with the adverse effect of the medications.Adverse effect of antineoplastic and immunosuppressive drugs, sequela (T451X5S): The code T451X5S is assigned to a sequela encounter for an adverse effect of antineoplastic and immunosuppressive drugs.The patient reports that the symptoms started a few weeks after the initiation of the antineoplastic and immunosuppressive drugs. There is no evidence of intentional overdose or poisoning.Treatment includes discontinuation of the offending drugs, supportive care for anemia and thrombocytopenia, and close monitoring of blood counts.The patient responded well to the treatment and was discharged with instructions for follow-up blood tests in two weeks.58FemaleCaucasian"
    },
    "4896": {
        "explanation_text": "Underdosing of antineoplastic and immunosuppressive drugs, initial encounter.",
        "symptom_text": "The patient has a history of stage III lung cancer and has been receiving chemotherapy and immunosuppressive therapy for the past six months.The patient presents with fatigue, decreased appetite, and weight loss.Recent blood work shows decreased white blood cell count and low neutrophil levels.Underdosing of antineoplastic and immunosuppressive drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with symptoms consistent with underdosing of antineoplastic and immunosuppressive drugs.'Patient reports difficulty in adhering to the prescribed medication schedule due to financial constraints.The patient has been started on a new dosing regimen for the antineoplastic and immunosuppressive drugs. A financial counselor has been consulted to explore assistance programs.The patient's condition has stabilized, and arrangements have been made for close follow-up to ensure proper dosing and medication adherence.58FemaleCaucasian"
    },
    "4897": {
        "explanation_text": "Adverse effect of vitamins, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional nausea but no other significant medical history related to antineoplastic, anticoagulant, or other excluded drug categories.The patient presented with mild gastrointestinal discomfort, skin rash, and fatigue, which started shortly after initiating a new vitamin supplement regimen.Laboratory tests revealed elevated levels of specific vitamins in the blood, confirming hypervitaminosis as the cause of the adverse effects.Adverse effect of vitamins, initial encounter. This code is assigned due to the patient's presentation with symptoms and lab results indicative of hypervitaminosis following the initiation of a new vitamin supplement regimen.The patient reports adherence to the prescribed vitamin regimen and denies any recent changes in diet or medication use other than the new vitamin supplement. Physical examination shows no other concerning findings.The patient was advised to discontinue the vitamin supplements, increase fluid intake, and follow up for symptom monitoring. Symptomatic treatment for gastrointestinal discomfort and rash was initiated.The patient responded well to treatment, with symptoms gradually resolving. Upon discharge, the patient was asymptomatic with recommendations for close monitoring of vitamin levels in the future.42FemaleCaucasian"
    },
    "4898": {
        "explanation_text": "Adverse effect of iron and its compounds, initial encounter.",
        "symptom_text": "The patient has a history of iron deficiency anemia and has been prescribed iron supplements for the last six months.The patient presents with nausea, vomiting, abdominal pain, and dark stools after recently starting a new iron supplement.Lab tests show elevated serum iron levels and evidence of gastrointestinal bleeding.Adverse effect of iron and its compounds, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of nausea, vomiting, abdominal pain, and dark stools after starting iron supplements. Lab results indicate elevated serum iron levels and gastrointestinal bleeding.'The patient reports a temporal relationship between the initiation of iron supplements and the onset of symptoms. Physical examination reveals epigastric tenderness.Discontinuation of the iron supplement, initiation of intravenous fluids, and monitoring for hemodynamic stability.The patient's symptoms improved with supportive care, and discharge instructions include avoiding iron supplements and follow-up with a gastroenterologist for further evaluation if symptoms recur.45FemaleCaucasian"
    },
    "4899": {
        "explanation_text": "Poisoning by anticoagulants, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and was recently started on anticoagulant therapy with warfarin.Upon presentation, the patient complained of easy bruising, prolonged bleeding from minor cuts, and blood in the urine.Laboratory tests revealed an elevated INR (International Normalized Ratio) of 4.5, confirming the anticoagulant effect.Poisoning by anticoagulants, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient presented with symptoms of easy bruising, prolonged bleeding, and elevated INR after recent initiation of anticoagulant therapy with warfarin.'The patient denied any intentional overdose or misuse of medication. The history and clinical presentation are consistent with accidental poisoning by anticoagulants.The patient was treated with vitamin K to reverse the anticoagulant effect and transfused with packed red blood cells due to significant blood loss.The patient responded well to treatment, with normalization of INR and resolution of bleeding symptoms. Discharged home with close follow-up for monitoring.68MaleCaucasian"
    }
}